Immupharma Share Discussion Threads

[w1ndjammer] 21/2/2018 16:52

WorldQuant gone sub 0.5%


WJ.

[growthinvestor2001] 21/2/2018 16:52

The short is no longer showing as 0.51% ....

[che7win] 21/2/2018 16:50

Divine, It's criminal watching the gang of mendacious derampers here that fleeced shareholders out at 110p.I want to see these above 200p before results are announced, we are on our way folks.

[divinessence] 21/2/2018 16:42

Che7 as I said before those who were in IMM for long time and sold out were cheated with shorting scam. It's unethical and theft, cannot be justified no matter how you try.

However if readout is positive then getting in at today's price is still very cheap. I bought more today. Time will tell.

[sportbilly1976] 21/2/2018 16:38

Positive closing auction too

[che7win] 21/2/2018 16:36

The ramping crew have arrived, this material opportunity is getting out to a wider audience....and fast.What are those long term followers who have researched this for years and who have sold some or sold out going to do if this keeps rising day in day out from here?I feel sorry for those who may have to watch this rising day in, day out whilst thinking what could have been.Those who sold at 110p, what were you thinking? Seems Smart money moving in here ahead of results.

[che7win] 21/2/2018 16:32

Agreed Scrutable.Best regards to you.

[scrutable] 21/2/2018 16:31

che7wyn

The appetite of BigPharma for blockbusters is greater than the supply. Dealing satisfactorily with auto-immune disease will be a first. Not on the scale of penicillin but it also heralds the advance of a family/generation of drugs making life better for tens of millions asoup of solutions.

[che7win] 21/2/2018 16:29

LOoks like this rise is only starting.

[albanyvillas] 21/2/2018 16:29

190p tomorrow

[master rsi] 21/2/2018 16:28

Trying to hold into 130p bid earlier and since is a BREAKOUT from the earlier 129 v 131p range

[hottingup] 21/2/2018 16:27

Management have suggested Lupuzor has a 95% gross profit margin. Being a peptide, it can be produced more cheaply than alternatives like Benlysta.

[lodgeview] 21/2/2018 16:19

£3.27? And they are going to sell it at circa $20,000 per annum. Wow that's 99.9% profit!

[plentymorefish] 21/2/2018 16:15

Not sure of the exact cost but I know it's more than £3.27

[lodgeview] 21/2/2018 16:10

How much does it cost IMM to supply Lupuzor to one patient per annum?

[che7win] 21/2/2018 16:00

Material chance we get back to 200p at this rate pre results.I was happily buying at 182p when we heard patients requesting to continue on Lupuzor.

[quiche66] 21/2/2018 15:58

Great to see the recent rises here. Hopefully we will get a nice steady rise into results up to the placing price of 144p, or above. Looking at results anytime in March I would say. GLA

[che7win] 21/2/2018 15:54

Scrutable, There is not a chance on successful phase 3 that this will at any time get anywhere near 200p IMHO.I would be buying like crazy, can you imagine a £280m market cap (200p) for a drug with a potential market of $30billion revenue at $20,000 dollars per year?Not a chance IMHO, more like 800p.

[hottingup] 21/2/2018 15:54

"exponential potentially"

[hottingup] 21/2/2018 15:53

Tim McCarthy (IMM Chairman) 18/1/2018

"This [Lupuzor] could be selling in the billions of dollars per year, every year...We are ticking all the boxes in terms of the market potential, the profile of drug [Lupuzor] the lack of competition, we as a company own it 100%, so going on from here, the benefit to our shareholders in terms of the uplift in value of IMM based on this drug is exponential potentially..."

27 min 2 sec:

[arcadian] 21/2/2018 15:53

Improved sentiment and a rising share price are welcome but are not factual evidence of Phase 3 results notwithstanding the repetition of previous statements, encouraging though they may be.

For me it`s still all about how and from whom we will learn about the crucial "facts" and what room for manoeuvre there will be once we know.

[che7win] 21/2/2018 15:46

Mm1, I'm pretty certain they have a number of companies that are interested.From IMM's point of view, they have played a blinder, taking 100% ownership and not doing a deal until phase three results are known.Value increases exponentially in that case.